Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia
Authors
Keywords
Antipsychotics, Cannabis, Cannabinoid receptor, Endocannabinoid, Psychosis, Schizophrenia
Journal
MOLECULAR NEUROBIOLOGY
Volume 54, Issue 1, Pages 768-778
Publisher
Springer Nature
Online
2016-01-15
DOI
10.1007/s12035-016-9697-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cannabis use and the risk of developing a psychotic disorder
- (2015) WAYNE HALL et al. World Psychiatry
- The endocannabinoid system: An emotional buffer in the modulation of memory function
- (2014) Maria Morena et al. NEUROBIOLOGY OF LEARNING AND MEMORY
- Impaired Fear Memory Specificity Associated with Deficient Endocannabinoid-Dependent Long-Term Plasticity
- (2014) Jonathan W Lovelace et al. NEUROPSYCHOPHARMACOLOGY
- The endocannabinoid system and appetite: relevance for food reward
- (2014) Gerry Jager et al. NUTRITION RESEARCH REVIEWS
- Endocannabinoid Modulation of Cortical Up-States and NREM Sleep
- (2014) Matthew J. Pava et al. PLoS One
- Endogenous cannabinoid release within prefrontal-limbic pathways affects memory consolidation of emotional training
- (2014) Maria Morena et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effects of cannabinoid and vanilloid drugs on positive and negative-like symptoms on an animal model of schizophrenia: The SHR strain
- (2014) Valéria Almeida et al. SCHIZOPHRENIA RESEARCH
- The Endocannabinoid System as a Potential Therapeutic Target for Pain Modulation
- (2014) Ahmet Ulugol Balkan Medical Journal
- Motivational Deficits and Cognitive Test Performance in Schizophrenia
- (2014) Gagan Fervaha et al. JAMA Psychiatry
- Long-term consequences of adolescent cannabinoid exposure in adult psychopathology
- (2014) Justine Renard et al. Frontiers in Neuroscience
- Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain
- (2014) Raquel Levin et al. Frontiers in Pharmacology
- The Endocannabinoid System in Energy Homeostasis and the Etiopathology of Metabolic Disorders
- (2013) Cristoforo Silvestri et al. Cell Metabolism
- The endocannabinoid system and emotional processing: A pharmacological fMRI study with ∆9-tetrahydrocannabinol
- (2013) Matthijs G. Bossong et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Cannabidiol as a potential treatment for psychosis
- (2013) C.D. Schubart et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Neuregulin-1 Impairs the Long-term Depression of Hippocampal Inhibitory Synapses by Facilitating the Degradation of Endocannabinoid 2-AG
- (2013) H. Du et al. JOURNAL OF NEUROSCIENCE
- Alterations of prefrontal cortex GABAergic transmission in the complex psychotic-like phenotype induced by adolescent delta-9-tetrahydrocannabinol exposure in rats
- (2013) Erica Zamberletti et al. NEUROBIOLOGY OF DISEASE
- Peripheral Endocannabinoid System Dysregulation in First-Episode Psychosis
- (2013) Miquel Bioque et al. NEUROPSYCHOPHARMACOLOGY
- Phencyclidine-Induced Social Withdrawal Results from Deficient Stimulation of Cannabinoid CB1 Receptors: Implications for Schizophrenia
- (2013) Alexandre Seillier et al. NEUROPSYCHOPHARMACOLOGY
- Quantification of endocannabinoids in postmortem brain of schizophrenic subjects
- (2013) Carolina Muguruza et al. SCHIZOPHRENIA RESEARCH
- The Endocannabinoid System and the Treatment of Mood and Anxiety Disorders
- (2012) Matthew Hill et al. CNS & Neurological Disorders-Drug Targets
- Effects of Cannabis Use on Human Brain Structure in Psychosis: A Systematic Review Combining In Vivo Structural Neuroimaging and Post Mortem Studies
- (2012) Charlotte Rapp et al. CURRENT PHARMACEUTICAL DESIGN
- Endocannabinoids in Amygdala and Nucleus Accumbens Mediate Social Play Reward in Adolescent Rats
- (2012) V. Trezza et al. JOURNAL OF NEUROSCIENCE
- Binding of a tritiated inverse agonist to cannabinoid CB1 receptors is increased in patients with schizophrenia
- (2012) Kimberly J. Jenko et al. SCHIZOPHRENIA RESEARCH
- The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity
- (2012) Mireille Alhouayek et al. TRENDS IN MOLECULAR MEDICINE
- Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
- (2012) F M Leweke et al. Translational Psychiatry
- The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors
- (2011) J. R. Savinainen et al. Acta Physiologica
- Paranoid Schizophrenia is Characterized by Increased CB1 Receptor Binding in the Dorsolateral Prefrontal Cortex
- (2011) Victoria S Dalton et al. NEUROPSYCHOPHARMACOLOGY
- Deletion of CB2 Cannabinoid Receptor Induces Schizophrenia-Related Behaviors in Mice
- (2011) Antonio Ortega-Alvaro et al. NEUROPSYCHOPHARMACOLOGY
- Cannabis use and cognitive dysfunction
- (2011) Amresh Shrivastava et al. Indian Journal of Psychiatry
- Quantification of brain endocannabinoid levels: methods, interpretations and pitfalls
- (2010) Matthew W Buczynski et al. BRITISH JOURNAL OF PHARMACOLOGY
- Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models
- (2010) Daniel T Malone et al. BRITISH JOURNAL OF PHARMACOLOGY
- Efficacy of atypical v. typical antipsychotics in the treatment of early psychosis: meta-analysis
- (2010) Nicolas A. Crossley et al. BRITISH JOURNAL OF PSYCHIATRY
- Cannabinoid CB1 receptor antagonism prevents neurochemical and behavioural deficits induced by chronic phencyclidine
- (2010) Cinzia Guidali et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Dopaminergic Modulation of Endocannabinoid-Mediated Plasticity at GABAergic Synapses in the Prefrontal Cortex
- (2010) C. Q. Chiu et al. JOURNAL OF NEUROSCIENCE
- Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMAR
- (2010) Dean F. Wong et al. NEUROIMAGE
- Disruption of Frontal Theta Coherence by Δ9-Tetrahydrocannabinol is Associated with Positive Psychotic Symptoms
- (2010) Paul D Morrison et al. NEUROPSYCHOPHARMACOLOGY
- Cannabinoid CB1 Receptor Immunoreactivity in the Prefrontal Cortex: Comparison of Schizophrenia and Major Depressive Disorder
- (2010) Stephen M Eggan et al. NEUROPSYCHOPHARMACOLOGY
- N-acylethanolamine metabolism with special reference to N-acylethanolamine-hydrolyzing acid amidase (NAAA)
- (2010) Natsuo Ueda et al. PROGRESS IN LIPID RESEARCH
- AVE1625, a cannabinoid CB1 receptor antagonist, as a co-treatment with antipsychotics for schizophrenia: improvement in cognitive function and reduction of antipsychotic-side effects in rodents
- (2010) Mark D. Black et al. PSYCHOPHARMACOLOGY
- IN VIVO PET IMAGING OF CEREBRAL TYPE 1 CANNABINOID RECEPTOR AVAILABILITY IN PATIENTS WITH SCHIZOPHRENIA
- (2010) Jenny Ceccarini et al. SCHIZOPHRENIA RESEARCH
- Signaling pathways in schizophrenia: emerging targets and therapeutic strategies
- (2010) Caline S. Karam et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Brain Cannabinoid CB2 Receptor in Schizophrenia
- (2009) Hiroki Ishiguro et al. BIOLOGICAL PSYCHIATRY
- Cannabis and psychosis/schizophrenia: human studies
- (2009) Deepak Cyril D’Souza et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats
- (2009) Alexandre Seillier et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Blockade of 2-Arachidonoylglycerol Hydrolysis by Selective Monoacylglycerol Lipase Inhibitor 4-Nitrophenyl 4-(Dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) Enhances Retrograde Endocannabinoid Signaling
- (2009) B. Pan et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: A neuroprotective therapeutic modality
- (2009) Jeannie Hwang et al. LIFE SCIENCES
- Cannabinoids as pharmacotherapies for neuropathic pain: From the bench to the bedside
- (2009) Elizabeth J. Rahn et al. Neurotherapeutics
- Role of cannabis and endocannabinoids in the genesis of schizophrenia
- (2009) Emilio Fernandez-Espejo et al. PSYCHOPHARMACOLOGY
- Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment
- (2009) Leyre Urigüen et al. PSYCHOPHARMACOLOGY
- The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
- (2009) O. D. Howes et al. SCHIZOPHRENIA BULLETIN
- Cannabinoid receptor 1 gene (CNR1) and susceptibility to a quantitative phenotype for hebephrenic schizophrenia
- (2008) Iván Chavarría-Siles et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- Reduced Cortical Cannabinoid 1 Receptor Messenger RNA and Protein Expression in Schizophrenia
- (2008) Stephen M. Eggan et al. ARCHIVES OF GENERAL PSYCHIATRY
- Non-adherence to antipsychotic medication, relapse and rehospitalisation in recent-onset schizophrenia
- (2008) Gunnar Morken et al. BMC Psychiatry
- Association of cannabis use with prodromal symptoms of psychosis in adolescence
- (2008) Jouko Miettunen et al. BRITISH JOURNAL OF PSYCHIATRY
- Cannabis and schizophrenia: towards a cannabinoid hypothesis of schizophrenia
- (2008) Kirsten R Müller-Vahl et al. Expert Review of Neurotherapeutics
- Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia
- (2008) Daniela Vigano et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapy
- (2008) Stéphane Potvin et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Biology of endocannabinoid synthesis system
- (2008) Jun Wang et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Postsynaptic localization of CB2 cannabinoid receptors in the rat hippocampus
- (2008) Alicia Brusco et al. SYNAPSE
- The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin
- (2007) R G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
- (2007) A Thomas et al. BRITISH JOURNAL OF PHARMACOLOGY
- Effect of social isolation on CB1 and D2 receptor and fatty acid amide hydrolase expression in rats
- (2007) D.T. Malone et al. NEUROSCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now